Camptothecin
Showing 26 - 50 of 166
Cancer, Solid Tumor Trial in Scottsdale, Duarte, Farmington (Camptothecin (CPT) conjugated to a linear, cyclodextrin-based
Completed
- Cancer
- Solid Tumor
- Camptothecin (CPT) conjugated to a linear, cyclodextrin-based polymer
-
Scottsdale, Arizona
- +2 more
May 26, 2020
Colorectal Cancer Trial in Beijing (68Ga-EB-ss-CPT, 64Cu-EB-ss-CPT)
Recruiting
- Colorectal Cancer
-
Beijing, Beijing, ChinaChinese Academy of Medical Science & Peking Union Medical Colleg
Jun 6, 2023
Malignant Lymphoma of Extranodal and/or Solid Organ Site, Solid Tumor Trial in San Antonio (CZ48)
Unknown status
- Malignant Lymphoma of Extranodal and/or Solid Organ Site
- Solid Tumor
-
San Antonio, TexasUniversity of Texas Health Science Center
Jul 22, 2019
Gastric Cancer, Small-cell Lung Cancer Trial in China, Korea, Republic of, Taiwan (EP0057, Olaparib tablets)
Not yet recruiting
- Gastric Cancer
- Small-cell Lung Cancer
- EP0057
- Olaparib tablets
-
Shanghai, Changning District, 交通大学 邮政编码, China
- +20 more
Nov 1, 2022
Carcinoma, Small Cell Trial in Hwasun (Belotecan, Etoposide, Cisplatin)
Completed
- Carcinoma, Small Cell
- Belotecan
- +2 more
-
Hwasun, Korea, Republic ofChonnam National University Hwasun Hospital
Aug 2, 2021
High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma Trial in Worldwide (Dinutuximab, Eflornithine
Recruiting
- High Risk Neuroblastoma
- +2 more
- Dinutuximab
- +4 more
-
Birmingham, Alabama
- +141 more
Dec 28, 2022
Locally Advanced Unresectable or Metastatic Solid Tumors Trial in Randwick, Sunshine Coast, Clayton (IBI354)
Not yet recruiting
- Locally Advanced Unresectable or Metastatic Solid Tumors
- IBI354
-
Randwick, New South Wales, Australia
- +2 more
Dec 8, 2022
Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle
Recruiting
- Muscle Invasive Bladder Carcinoma
- +2 more
- Lymphadenectomy
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 9, 2023
HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)
Recruiting
- HRD Cancer
- +2 more
- Berzosertib
- Sacituzumab Govitecan
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Lung Tumors, NSCLC Trial in Greenville (Irinotecan, Cisplatin)
Terminated
- Lung Neoplasms, Non-Small Cell Lung Cancer
-
Greenville, North CarolinaLeo W Jenkins Cancer Center
Aug 20, 2019
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- Metastatic Malignant Solid Neoplasm
- Biopsy
- +3 more
- (no location specified)
Jan 18, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Duarte
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Copper Cu 64-DOTA-Trastuzumab
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 22, 2022
PRETEXT Stage 1 Hepatoblastoma, PRETEXT Stage 2 Hepatoblastoma, PRETEXT Stage 3 Hepatoblastoma Trial in Worldwide (drug, other,
Active, not recruiting
- PRETEXT Stage 1 Hepatoblastoma
- +3 more
- Cisplatin
- +9 more
-
Birmingham, Alabama
- +208 more
Jan 25, 2023
Osteosarcoma, Recurrent Osteosarcoma Trial in United States (Trastuzumab Deruxtecan)
Suspended
- Osteosarcoma
- Recurrent Osteosarcoma
- Trastuzumab Deruxtecan
-
Birmingham, Alabama
- +27 more
Oct 21, 2022
Metastatic Pancreatic Adenocarcinoma Trial in Worldwide (Irinotecan liposome injection, Folinic Acid, 5-Fluorouracil)
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Irinotecan liposome injection
- +2 more
-
Bedford Park, Australia
- +35 more
Jan 24, 2023
HER2-Positive Breast Carcinoma, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States
Recruiting
- Advanced Malignant Solid Neoplasm
- +4 more
- Biopsy
- +3 more
-
Bethesda, Maryland
- +4 more
Jan 21, 2023
NSCLC Trial in Russian Federation, Ukraine (CRLX101, Best Supportive Care)
Completed
- Non-Small Cell Lung Cancer
- CRLX101
- Best Supportive Care
-
Saransk, Republic Of Mordovia, Russian Federation
- +24 more
May 26, 2020
Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Cancer Trial in United States (drug,
Recruiting
- Early-stage Breast Cancer
- +6 more
- Anastrozole
- +2 more
-
Fullerton, California
- +8 more
Sep 19, 2022
Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Haven (procedure, drug, biological)
Recruiting
- Metastatic Malignant Solid Neoplasm
- Unresectable Malignant Solid Neoplasm
- Biopsy
- +2 more
-
Boston, Massachusetts
- +2 more
Jan 25, 2023
Triple-negative Breast Cancer Trial (IMMU-132 infusion is administered to participants in one arm for the study, IMMU-132 plus
Withdrawn
- Triple-negative Breast Cancer
- IMMU-132 infusion is administered to participants in one arm for the study
- IMMU-132 plus Carboplatin infusion
- (no location specified)
Aug 12, 2021
Endometrial Serous Adenocarcinoma, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States
Recruiting
- Endometrial Serous Adenocarcinoma
- +2 more
- Biopsy
- +3 more
-
Phoenix, Arizona
- +3 more
Feb 2, 2023
Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,
Not yet recruiting
- Metastatic Gastric Adenocarcinoma
- +2 more
- nal-IRI /Experimental
- +2 more
- (no location specified)
Jun 25, 2023
Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Philadelphia (Oxaliplatin,
Completed
- Pancreatic Adenocarcinoma
- +4 more
- Oxaliplatin
- +4 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 15, 2020